Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” second quarter 2025 ...

Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 ...

Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Life sciences firm Waters will take on $4 billion in debt, and issue 39.2% of its shares to Becton Dickinson shareholders.

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Universal Health Realty's dividend has been hiked annually for four decades. That's a pretty good streak, even though it ...

Becton Dickinson & Co. closed 29.02% below its 52-week high of $251.99, which the company reached on February 3rd.

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.